Nahdi Medical Company (TADAWUL:4164)

Nahdi Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 12, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	15,002	17,810	21,736	-	-	-
Market Cap Growth	-8.74%	-18.06%	-	-	-	-
Enterprise Value	15,739	17,991	22,301	-	-	-
Last Close Price	115.40	131.68	155.43	-	-	-
PE Ratio	18.00	19.95	24.48	-	-	-
Forward PE	17.48	20.42	23.26	-	-	-
PS Ratio	1.61	2.04	2.52	-	-	-
PB Ratio	6.23	7.23	9.69	-	-	-
P/TBV Ratio	7.30	7.39	9.90	-	-	-
P/FCF Ratio	15.10	17.55	15.33	-	-	-
P/OCF Ratio	12.69	13.01	13.03	-	-	-
PEG Ratio	77.38	6.59	3.46	-	-	-
EV/Sales Ratio	1.69	2.06	2.59	-	-	-
EV/EBITDA Ratio	10.42	15.24	18.71	-	-	-
EV/EBIT Ratio	18.18	18.73	22.31	-	-	-
EV/FCF Ratio	15.84	17.73	15.73	-	-	-
Debt / Equity Ratio	0.62	0.48	0.52	0.85	0.59	0.68
Debt / EBITDA Ratio	0.98	0.76	0.74	0.93	0.85	0.93
Debt / FCF Ratio	1.49	1.16	0.82	1.29	0.96	1.08
Asset Turnover	1.68	1.69	1.87	1.80	1.95	2.28
Inventory Turnover	3.95	4.07	4.47	4.26	4.77	4.73
Quick Ratio	0.51	0.66	0.80	0.42	0.78	0.57
Current Ratio	1.49	1.69	1.70	1.40	1.72	1.60
Return on Equity (ROE)	35.58%	37.93%	46.16%	44.13%	43.96%	39.96%
Return on Assets (ROA)	9.80%	11.64%	13.54%	12.65%	13.64%	15.09%
Return on Capital (ROIC)	14.89%	17.04%	19.61%	18.04%	19.12%	22.17%
Return on Capital Employed (ROCE)	21.97%	25.69%	29.09%	30.19%	29.71%	28.26%
Earnings Yield	5.56%	5.01%	4.08%	-	-	-
FCF Yield	6.62%	5.70%	6.52%	-	-	-
Dividend Yield	4.77%	4.18%	3.42%	-	-	-
Payout Ratio	85.79%	80.10%	33.82%	155.07%	63.01%	72.25%
Buyback Yield / Dilution	-	-	-	-2500.00%	-
Total Shareholder Return	4.77%	4.18%	3.42%	-	-2500.00%	-

Source: S&P Capital IQ. Standard template. Financial Sources.